Contact Us
Partner Login
FDA 510(k) Submission Services
A2LA Accredited · ISO/IEC 17025 · Certificate #2381.01

FDA 510(k) Submission Services

Medical device manufacturers seeking FDA clearance require comprehensive testing data that meets regulatory standards. MiCOM Labs provides A2LA-accredited testing services and expert support for 510(k) submissions, helping you demonstrate substantial equivalence with test results accepted by FDA reviewers.

Schedule a Free 510(k) Consultation

Required Testing Data for 510(k) Submissions

FDA submissions require test data from laboratories holding ISO/IEC 17025 accreditation. Test results must meet documentation and traceability standards recognized by regulatory authorities. MiCOM Labs maintains A2LA accreditation under ISO/IEC 17025 (Certificate #2381.01), ensuring test results meet FDA submission requirements.

Electrical Safety Testing

Medical electrical equipment requires testing in accordance with IEC 60601-1. Laboratory instruments require testing in accordance with IEC 61010. These standards evaluate electrical hazards, mechanical risks, thermal dangers, and other concerns.

Test parameters include:

•

Leakage current measurements at 100% mains voltage

•

Protective earth resistance verification

•

Essential performance validation

•

Single fault condition testing

Electromagnetic Compatibility Testing

IEC 60601-1-2 mandates EMC testing for medical electrical equipment. Testing validates that devices operate reliably in clinical environments without causing harmful interference.

Wireless Device Testing

Connected medical devices require RF compliance testing for FCC Part 15, Part 18, or Part 27, depending on wireless technology. Testing demonstrates that devices meet emission limits and operate without causing harmful interference.

Wireless technologies supported:

  • Wi-Fi-enabled diagnostic equipment
  • Bluetooth medical sensors
  • Cellular-connected patient monitors
  • RFID medical tracking devices

Understanding the 510(k) Premarket Notification Process

The 510(k) pathway allows manufacturers to demonstrate that a medical device is substantially equivalent to a legally marketed predicate device. This premarket notification applies to most Class II devices and some Class I devices not exempt from 510(k) requirements.

A device is substantially equivalent when it shares the same intended use as the predicate, and either has the same technological characteristics or has different technological characteristics that do not raise different questions of safety and effectiveness.

The FDA reported an average review time of 163 days for 510(k) submissions in 2023. Approximately 70% of medical devices entering the U.S. market follow the 510(k) pathway.

Submission Type Review Timeline Standard User Fee (FY 2025) Small Business Fee
Traditional 510(k) 90 days (target) $24,335 $6,084
Special 510(k) 30 days (target) $24,335 $6,084
Abbreviated 510(k) 90 days (target) $24,335 $6,084
Source: FDA FY 2025 Medical Device User Fees
Request Your Testing Proposal →

Predicate Device Selection Strategy

Selecting an appropriate predicate device is foundational to 510(k) success. The predicate must be a legally marketed device that was cleared under a previous 510(k), classified under the De Novo process, or legally marketed before May 28, 1976.

A legally marketed predicate cannot be a device in violation of the FD&C Act. The predicate device must share the same intended use as your device. While recent 510(k) clearances are often selected as predicates, any legally marketed device may serve as a predicate.

Predicate Selection Factor Consideration
Intended Use Must match exactly
Technological Characteristics Same characteristics preferred
Different Technology Must not raise different safety questions
Clearance Status Must be legally marketed in the U.S.
Violation Status Cannot be in violation of the FD&C Act

Substantial Equivalence Documentation Requirements

Demonstrating substantial equivalence requires comparative documentation between your device and the predicate. The submission must include device descriptions, comparisons of technological characteristics, and performance data.

FDA evaluates whether technological differences raise different questions of safety and effectiveness. When differences exist, manufacturers must provide performance data demonstrating that the device is as safe and effective as the predicate.

Performance data accepted by the FDA includes:

Clinical data from controlled studies

Non-clinical bench performance data

Engineering performance testing results

Sterility validation data

Electromagnetic compatibility results

Software validation documentation

Biocompatibility evaluation results

Contact Us About Your Testing Requirements →

Testing Services for Medical Device Compliance

MiCOM Labs provides comprehensive testing services for medical device manufacturers navigating FDA submission requirements.

Service Description Regulatory Benefit
A2LA-Accredited Testing ISO/IEC 17025 accredited laboratory operations Test results accepted in FDA submissions
Real-Time Test Monitoring MiTest® platform provides live project updates Access provisional results before final reports
Automated Testing Workflows The platform executes test protocols automatically Reduced testing time with comprehensive coverage
Certification Management MiCMS® platform tracks compliance documentation Streamlined workflow and automated status alerts

Source: MiCOM Labs Testing Capabilities

MiCOM Labs also holds ISO/IEC 17065 accreditation (Certificate #2381.02) as a certification body, enabling declarations of conformity accepted in multiple jurisdictions.

Schedule a Free 510(k) Consultation →

Testing Requirements for De Novo Submissions

FDA acceptance of De Novo submissions requires test data from laboratories holding ISO/IEC 17025 accreditation. Test results must meet documentation and traceability standards recognized globally by regulatory authorities.

Electrical Safety Testing

Medical electrical equipment requires testing in accordance with IEC 60601-1. Laboratory instruments require testing in accordance with IEC 61010. These standards evaluate:

Insulation integrity and protective earth connections

Leakage current limits under normal and fault conditions

Temperature rise on accessible surfaces

Mechanical stability and resistance to stress

Protection against fluid ingress

Electromagnetic Compatibility Testing

IEC 60601-1-2 establishes EMC testing requirements for medical electrical equipment. Testing validates that devices operate reliably in clinical environments without causing harmful interference.

Emissions Testing

Test Type Purpose Standard
Radiated Emissions Prevents interference with nearby medical equipment IEC 60601-1-2, EN 55032, FCC Part 15
Conducted Emissions Eliminates power line interference in healthcare facilities IEC 60601-1-2, EN 55032
Harmonic Current Protects power grid stability IEC 61000-3-2
Voltage Fluctuations Maintains power quality for life-supporting equipment IEC 61000-3-3

Immunity Testing

Test Type Application Standard
Radiated Immunity Ensures function during RF exposure from wireless equipment IEC 61000-4-3, IEC 60601-1-2
Conducted Immunity Validates operation during power line disturbances IEC 61000-4-6
ESD Immunity Prevents system failure from static discharge IEC 61000-4-2
Surge Immunity Protects against transient-induced failures IEC 61000-4-5

Wireless Device Testing

Connected medical devices must pass RF compliance testing under FCC Part 15, Part 18, or Part 27, depending on the wireless technology. These tests verify emissions limits and ensure devices do not cause harmful interference.

MiCOM Labs performs testing up to 220 GHz and provides certification for FCC, ISED, EU RED, UKCA, and Japan MIC requirements.

Contact Us About Your Testing Requirements →

Pre-Submission Strategies to Reduce Review Time

Engaging with the FDA before formal submission prevents costly redesigns and regulatory setbacks. Two key pre-submission mechanisms help manufacturers clarify requirements early in development.

513(g) Request for Classification

Timeline: 60 days | Fee: $7,301 (standard)

Provides formal FDA determination of device classification

Pre-Submission (Q-Sub) Consultation

Timeline: Varies | Fee: No standard fee

Discussion with FDA on testing, documentation, and requirements

Source: FDA Pre-Submission Programs

The 513(g) request ensures clarity on device classification early in development. The Pre-Submission consultation allows discussion with FDA reviewers to identify gaps in testing documentation before formal submission.

Contact Us About Your Testing Requirements
Direct Certification Markets

Global Market Access Beyond FDA

Medical device manufacturers targeting international markets require testing and certification across multiple jurisdictions. MiCOM Labs holds direct certification authority in five major markets through bilateral mutual recognition agreements.

Market Regulatory Body MiCOM Labs Status
🇺🇸 United States
FCC Telecommunication Certification Body (TCB)
🇨🇦 Canada
ISED Foreign Certification Body (FCB)
🇪🇺 European Union
CE Notified Body under US-EU MRA
🇬🇧 United Kingdom
UKCA Approved Body under US-UK MRA
🇯🇵 Japan
MIC Registered Certification Body (RCB)
🇺🇸 United States
FCC Telecommunication Certification Body (TCB)
🇨🇦 Canada
ISED Foreign Certification Body (FCB)
🇪🇺 European Union
CE Notified Body under US-EU MRA
🇬🇧 United Kingdom
UKCA Approved Body under US-UK MRA
🇯🇵 Japan
MIC Registered Certification Body (RCB)

Source: FDA Pre-Submission Programs

MiCOM Labs also conducts testing for nine additional economies under the APEC TEL MRA Phase I. These include Australia, Taiwan, Hong Kong, Malaysia, New Zealand, South Korea, Singapore, Vietnam, and Mexico.

510(k) Submission Process Timeline

Understanding the complete timeline from testing through clearance helps manufacturers plan product launches effectively.

1–2 days

Initial Assessment

Equipment specifications reviewed, applicable standards identified

2–3 days

Test Planning

Test protocol developed, sample requirements documented

1–2 weeks

Physical Testing

Electrical safety, EMC evaluation, RF testing, and environmental validation

2–3 days

Report Generation

ISO/IEC 17025-compliant test reports issued

1–2 weeks

Submission Preparation

Documentation compiled, substantial equivalence demonstrated

90 days

FDA Review

Premarket notification review (target)

Initial Assessment

1–2 days

Equipment specifications reviewed, applicable standards identified

Test Planning

2–3 days

Test protocol developed, sample requirements documented

Physical Testing

1–2 weeks

Electrical safety, EMC evaluation, RF testing, and environmental validation

Report Generation

2–3 days

ISO/IEC 17025-compliant test reports issued

Submission Preparation

1–2 weeks

Documentation compiled, substantial equivalence demonstrated

FDA Review

90 days

Premarket notification review (target)

Source: MiCOM Labs Process Documentation; FDA Review Timelines

The FDA's 90-day review period begins after the submission is accepted. The actual review time in 2023 averaged 163 days. Additional time may be required if the FDA issues requests for additional information.

Contact MiCOM Labs Today

Industries Served

MiCOM Labs helps medical technology companies meet FDA and global compliance requirements across multiple sectors.

Medical & Clinical Labs

Testing for diagnostic systems, analyzers, and lab automation to meet safety and EMC standards.

Connected Health Devices

RF, EMC, and safety compliance for wireless monitors, telehealth, and remote diagnostic systems.

Diagnostic Equipment

Compliance testing for imaging accessories, lab equipment, and diagnostic analyzers in clinical settings.

Frequently Asked Questions

Devices qualify for De Novo when no legally marketed predicate exists, and the device presents low to moderate risk. The manufacturer must demonstrate that general controls or general controls with special controls provide reasonable assurance of safety and effectiveness.

Yes. Since the FDA final rule in October 2021, manufacturers can submit De Novo requests directly when they determine that no predicate device exists. This eliminates the need to obtain a not substantially equivalent determination first.

The FDA's review goal targets 150 FDA review days, excluding hold periods. Total time from testing initiation through final decision typically ranges from six to nine months, depending on device complexity and the completeness of initial documentation.

The device remains in Class III. Manufacturers must either submit a Premarket Approval (PMA) application or collect additional data to address the identified deficiencies and submit a new De Novo request.

MiCOM Labs provides comprehensive testing services for bench performance, electrical safety, EMC, and RF compliance. For clinical studies, we coordinate with qualified clinical research organizations while managing the overall compliance timeline.

Navigate De Novo Requirements with Expert Support

Medical device manufacturers benefit from early engagement with accredited testing laboratories that understand FDA submission requirements. Proper device classification, appropriate pathway selection, and comprehensive testing data reduce review delays and increase approval success rates.

MiCOM Labs delivers A2LA-accredited testing services for medical device manufacturers navigating FDA compliance requirements. Our automated testing platforms and direct certification authority in major markets reduce time-to-market while ensuring regulatory acceptance.

Contact MiCOM Labs to discuss your device specifications, target markets, and testing requirements. Receive a detailed proposal outlining applicable standards, testing scope, and regulatory timelines.

Request Your Project Proposal Today